THE EFFECT OF COMBINATION THERAPY WITH PEGINTERFERON ALFA-2B PLUS ENTECAVIR DURING 48 WEEKS FOR CHRONIC HEPATITIS B

被引：0
|
作者：
Inuzuka, Tadashi [1 ]
Takeda, Haruhiko [1 ]
Kanesaka, Takashi [1 ]
Kanesaka, Takashi [1 ]
Nakajima, Jun [1 ]
Matsuda, Fumihiro [1 ]
Sakamoto, Azusa [1 ]
Hatamaru, Keiichi [1 ]
Henmi, Shinichiro [1 ]
Ishikawa, Tetsuro [1 ]
Saito, Sumio [1 ]
Saito, Sumio [1 ]
Nishikawa, Hiroki [1 ]
Nishikawa, Hiroki [1 ]
Kita, Ryuichi [1 ]
Kimura, Toru [1 ]
Osaki, Yukio [1 ]
机构：
[1] Osaka Red Cross Hosp, Osaka, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1063A / 1063A
页数：1
相关论文
共 50 条
  • [21] Peginterferon alfa-2b plus ribavirin for chronic hepatitis C virus infection genotype 4
    Shiha, Gamal
    Elshennaw, Hassan
    Abbas, Baha
    Khaled, Zalata
    Attia, Mohamed
    Farouk, Doaa
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2006, 21 : A25 - A25
  • [22] Responses to peginterferon alfa-2a vs alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Luis Sandoval-Ramirez, Jorge
    Antonio Mata-Marin, Jose
    Huerta-Garcia, Gloria
    Enrique Gaytan-Martinez, Jesus
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2015, 9 (03): : 267 - 273
  • [23] Responses to peginterferon alfa-2a versus alfa-2b plus ribavirin in a Mexican population with chronic hepatitis C
    Sandoval, J.
    Mata, J.
    Gaytan, J.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 25 - 25
  • [24] Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders:: A report of 9 cases
    Buti, M
    Valdés, A
    Sánchez-Avila, F
    Esteban, R
    Lurie, Y
    HEPATOLOGY, 2003, 37 (05) : 1226 - 1227
  • [25] EFFICACY OF PEGINTERFERON ALFA-2A OR ALFA-2B IN TREATMENT OF HBEAG NEGATIVE CHRONIC HEPATITIS B INFECTION
    Karabay, Oguz
    Tuna, Nazan
    Esen, Saban
    HEPATOLOGY, 2011, 54 : 1061A - 1061A
  • [26] Peginterferon Alfa-2a Plus Ribavirin Is More Effective Than Peginterferon Alfa-2b Plus Ribavirin for Treating Chronic Hepatitis C Virus Infection
    Ascione, Antonio
    De Luca, Massimo
    Tartaglione, Maria Teresa
    Lampasi, Filippo
    Di Costanzo, Giovan Giuseppe
    Lanza, Alfonso Galeota
    Picciotto, Francesco Paolo
    Marino-Marsilia, Giuseppina
    Fontanella, Luca
    Leandro, Gioacchino
    GASTROENTEROLOGY, 2010, 138 (01) : 116 - 122
  • [27] Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirin
    Buti, M
    Sanchez-Avila, F
    Lurie, Y
    Stalgis, C
    Valdés, A
    Martell, M
    Esteban, R
    HEPATOLOGY, 2002, 35 (04) : 930 - 936
  • [28] Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Hepatitis C
    Hsu, Ching-Sheng
    Kao, Jia-Horng
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (18): : 1808 - 1809
  • [29] Effect of Combination Therapy Peginterferon Alfa-2B and Ribavirin on Prevention of Hepatocellular Carcinoma in Patients With Chronic Hepatitis C and Normal Aminotransferase Levels
    Honda, Takashi
    Katano, Yoshiaki
    Nakano, Satoshi
    Ishizu, Yoji
    Kuzuya, Teiji
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Goto, Hidemi
    GASTROENTEROLOGY, 2013, 144 (05) : S982 - S982
  • [30] EFFICACY OF COMBINATION THERAPY PEGINTERFERON ALFA-2B AND RIBAVIRIN ON PREVENTION OF HEPATOCELLULAR CARCINOMA IN OLDER PATIENTS WITH CHRONIC HEPATITIS C
    Honda, Takashi
    Katano, Yoshiaki
    Kuzuya, Teiji
    Tachi, Yoshihiko
    Hayashi, Kazuhiko
    Ishigami, Masatoshi
    Nakano, Isao
    Goto, Hidemi
    HEPATOLOGY, 2011, 54 : 840A - 840A
12345